Font Size: a A A
Keyword [nonalcoholic]
Result: 161 - 180 | Page: 9 of 10
161. Effect Of α-lipoic Acid(α-LA) On The Prevention And Treatment Of Nonalcoholic Fatty Liver In Rats
162. Liver Fat Kang Treats The Non-alcoholic Fatty Liver's Experimental Study
163. Preventive And Therapeutic Effect Of Network Antioxidants On The Rats With Nonalcoholic Steatohepatitis And Mechanism Study
164. Effect Of TNF-α On The SCAP-SREBP-1c Pathway Of Lipid Synthesis In A Model Of Hepatocyte Steatosis
165. The Role Of PPARγ,KLF6 And The Effects Of Rosiglitazone On The Development Of Nonalcoholic Steatohepatitis Related Fibrosis In Rats
166. Change Of Hepatocyte Protein KinaseB Expression In Rat With Nonalcoholic Fatty Liver Disease And The Intervention Study Of N-acetylcysteine, Melatonin
167. The Changes Of Activity And Clinical Significance Of Serum Paraoxonase One In Nonalcoholic Fatty Liver Disease Patients With Metabolic Syndrome
168. The Effect Of Telmisartan On Hepatic Fibrosis In Nonalcoholic Steatohepatitis Rat Model
169. The Expression And Significance Of Tumor Necrosis Factor α In Liver Of Patients With Nonalcoholic Steatohepatitis
170. Reviewed Clinical Analysis Of Primary Liver Cancer Of 1293 Cases: Non-alcoholic Fatty Liver Disease Is Probably One Of The Causes Of Primary Liver Cancer
171. SOCS-3 Expression In The NASH Rat Model And The Intervetion Study Of Telmisartan
172. Change And Clinical Significance Of Serum Retinol Binding Protein-4 Level In Patients With Type 2 Diabetes And Nonalcoholic Fatty Liver Disease
173. Relationship Between The Level Of Serum Amyloid A And Insulin Resistance In Patients Of Type 2 Diabetes Complicated With Nonalcoholic Fatty Liver Disease
174. Effect Of Visfatin And TNF-α In Type 2 Diabetes Mellitus Patiens With Nonalcoholic Fatty Liver Disease
175. The Study Of The Association Between PEMT Gene-774G/C Polymorphism And NAFLD
176. The Prevention And Therapeutic Effect Of Sophocarpine On Experimental Rat Nonalcoholic Steatohepatitis
177. 1.Analysis Of Relationship Between Insulin Resistance And Dyslipidemia In Type 2 Diabetes Mellitus Associated With Nonalcoholic Fatty Liver 2.The Preliminary Study On Vascular Endothelial Growth Factor Gene Therapy Of Skin Wounds In Diabetic Rats
178. The Relationship And Medication Between Peroxisome Proliferator-activated Receptor γ And Nonalcoholic Steatohepatitis
179. The Effect Of Jiangzhi Yigan Chongji On Cox-2 MRNA In Liver Of The Rats With Nonalcoholic Fatty Liver Disease
180. Experimental Research Of Jiangzhi Yigan Chongji On The Prevention And Treatment In Rats With Nonalcoholic Fatty Liver Disease
  <<First  <Prev  Next>  Last>>  Jump to